poster

Centanafadine Sustained Release in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: Secondary Outcomes From a Phase 2a Study

Centanafadine (CTN) is a norepinephrine/dopamine/serotonin reuptake inhibitor being investigated for the treatment of attention-deficit/hyperactivity disorder (ADHD). Secondary efficacy o...

10/26/2023

Changes in Metabolic Parameters Associated With Lumateperone in Late-Phase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder

This analysis of 2 pooled, 6-week, placebo-controlled monotherapy studies; a 6-month open-label extension (OLE) monotherapy study; and a 6-week, placebo-controlled adjunctive study evalua...

10/26/2023

Best Practices for Mental Health Treatment Teams From the Perspective of Certified Peer Support Specialists (CPSS): Results of a CPSS Roundtable

Certified Peer Support Specialists (CPSS) are people with lived experience who serve on treatment teams to help guide peers in their recovery process. A CPSS roundtable was convened to as...

10/26/2023

Budget Impact of Aripiprazole Once Every Two Months Long-Acting Injectable for Adult Patients with Bipolar-I Disorder in the US

In this study, a cost-offset analysis was conducted to evaluate the budget impact of introducing a new 2-monthly injectable formulation of aripiprazole in commercial health plans. In a hy...

10/26/2023

Budget Impact of Aripiprazole Once Every Two Months Long-Acting Injectable for Adult Patients with Schizophrenia in the US

A cost-offset analysis was conducted to evaluate the budget impact of introducing a new 2-monthly injectable formulation of aripiprazole in commercial health plans. In a hypothetical heal...

10/26/2023

Burden of Bipolar I Disorder on Clinical, Economic, and Humanistic Outcomes: Matched Analysis of US National Health and Wellness Survey Data

Patients with bipolar I disorder (BD-I) have an increased risk of obesity. This analysis assessed real-world outcomes in patients with BD-I vs controls using 2016/2020 National Health and...

10/26/2023

AXS-05 (Dextromethorphan-Bupropion) Significantly Improved Functioning in Major Depressive Disorder: Analysis of the Domains of the Sheehan Disability Scale

Major Depressive Disorder carries a substantial economic burden and personal impairment to those it affects. In the GEMINI and COMET trials, AXS-05 demonstrated substantial improvements i...

10/26/2023

Azithromycin in the Management of Clozapine-Induced Gastrointestinal Hypomotility

Clozapine induced gastrointestinal hypomotility (CIGH) is a common, often chronic, and potentially fatal complication of clozapine use. Although focus has historically been on constipatio...

10/26/2023

Baseline Demographics and Clinical Characteristics From OASIS: Observational Study of Long-Acting Injectables in Schizophrenia

OASIS was an observational study assessing real-world outcomes with atypical long-acting injectable (aLAI) antipsychotics in patients with schizophrenia. Most patients were treated in a c...

10/26/2023

Behavioral-, Neurologic-, Metabolic-, Endocrine-, and Cardiovascular-Related Adverse Events and Assessments in Patients With Schizophrenia Treated With TV-46000

TV-46000 is an FDA-approved long-acting subcutaneous antipsychotic (LASCA) formulation of risperidone that was shown to reduce time to impending relapse in patients with schizophrenia. Th...

10/26/2023

Tracks

Major Depressive Disorder

General Psychiatry

ADHD

MDD Insights

Schizophrenia Insights

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.

December 9 ⁠–⁠ December 11

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

May 28 ⁠–⁠ May 31

See Full Calendar

poster

Tracks

About

Specialties

Events

Year Round Education

HMP Global Products